A sleep intervention study comparing effects of sleep restriction and fragmentation on sleep and vigilance and the need for recovery.


Journal

Physiology & behavior
ISSN: 1873-507X
Titre abrégé: Physiol Behav
Pays: United States
ID NLM: 0151504

Informations de publication

Date de publication:
01 03 2020
Historique:
received: 31 10 2019
revised: 18 12 2019
accepted: 20 12 2019
pubmed: 25 12 2019
medline: 5 3 2021
entrez: 25 12 2019
Statut: ppublish

Résumé

Sleep deprivation is present not only in sleep disorders but also in numerous high demanding jobs and negatively affects cognition, performance and health. We developed a study design to distinguish the effects and need for recovery of two short-term disturbances - intermittent sleep fragmentation and partial sleep restriction. The randomized within-subjects design contained two weeks each with a baseline night, an intervention night of either sleep deprivation (5 h) or sleep fragmentation (light on every hour) and two undisturbed recovery nights. Twenty healthy male participants (mean age: 39.9 ± 7.4 years, mean BMI: 25.5 ± 2.2 kg/m²) underwent polysomnography, a psychomotor vigilance task (PVT), and subjective questions on well-being and sleep efficiency. Percentage-wise, the restriction night had significant less wake times, less light sleep (stage 1), less REM sleep, but more deep sleep (stage 3) than the fragmentation night. The restriction week displayed a significant recovery effect regarding these sleep stages. The sleep fragmentation week presented a significant recovery effect regarding sleep onset times. PVT performance showed only a slight recovery effect after sleep restriction. Subjective sleep quality was reduced after both interventions with a significant recovery effect during restriction week only. Short-term sleep restriction presented as a stronger sleep disturbance than short-term intermittent sleep fragmentation, including a stronger need for recovery. Already a one night sleep deprivation had an effect beyond two recovery days. The PVT was not sensitive enough to reveal significant changes. Next, autonomic parameters as possible biomarkers will be investigated.

Identifiants

pubmed: 31874181
pii: S0031-9384(19)31139-4
doi: 10.1016/j.physbeh.2019.112794
pii:
doi:

Types de publication

Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112794

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Naima Laharnar (N)

Charité - Universitaetsmedizin Berlin, Interdisciplinary Center of Sleep Medicine, Campus Charité Mitte, Luisenstr. 13, 10117 Berlin, Germany. Electronic address: naima.laharnar@charite.de.

Joanna Fatek (J)

Charité - Universitaetsmedizin Berlin, Interdisciplinary Center of Sleep Medicine, Campus Charité Mitte, Luisenstr. 13, 10117 Berlin, Germany.

Maria Zemann (M)

Charité - Universitaetsmedizin Berlin, Interdisciplinary Center of Sleep Medicine, Campus Charité Mitte, Luisenstr. 13, 10117 Berlin, Germany.

Martin Glos (M)

Charité - Universitaetsmedizin Berlin, Interdisciplinary Center of Sleep Medicine, Campus Charité Mitte, Luisenstr. 13, 10117 Berlin, Germany.

Katharina Lederer (K)

Advanced Sleep Research, Berlin, Germany.

Alexander V Suvorov (AV)

Russian Federation State Research Center, Institute of Biomedical Problems, Russian Academy of Science, Moscow, Russia.

Artem V Demin (AV)

Russian Federation State Research Center, Institute of Biomedical Problems, Russian Academy of Science, Moscow, Russia.

Thomas Penzel (T)

Charité - Universitaetsmedizin Berlin, Interdisciplinary Center of Sleep Medicine, Campus Charité Mitte, Luisenstr. 13, 10117 Berlin, Germany.

Ingo Fietze (I)

Charité - Universitaetsmedizin Berlin, Interdisciplinary Center of Sleep Medicine, Campus Charité Mitte, Luisenstr. 13, 10117 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH